[1] |
Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis[J]. Nat Rev Dis Primers, 2018,4(1):1. doi: 10.1038/s41572⁃018⁃0001⁃z.
|
[2] |
Rerknimitr P, Otsuka A, Nakashima C, et al. The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus[J]. Inflamm Regen, 2017,37:14. doi: 10.1186/s41232⁃017⁃0044⁃7.
|
[3] |
Hulshof L, Van′t Land B, Sprikkelman AB, et al. Role of microbial modulation in management of atopic dermatitis in children[J/OL]. Nutrients, 2017,9(8). pii: E854. doi: 10.3390/nu90 80854.
|
[4] |
Williams HC, Burney PG, Hay RJ, et al. The U.K. working party′s diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis[J]. Br J Dermatol, 1994,131(3):383⁃396.
|
[5] |
Lindberg M, Söderquist B. Atopic dermatitis and gut microbiota[J]. Br J Dermatol, 2017,176(2):297⁃298. doi: 10.1111/bjd. 15276.
|
[6] |
Kim JA, Kim SH, Kim IS, et al. Anti⁃inflammatory effects of a mixture of lactic acid bacteria and sodium butyrate in atopic dermatitis murine model[J]. J Med Food, 2018,21(7):716⁃725. doi: 10.1089/jmf.2017.4116.
|
[7] |
Thursby E, Juge N. Introduction to the human gut microbiota[J]. Biochem J, 2017,474(11):1823⁃1836. doi: 10.1042/BCJ2016 0510.
|
[8] |
Kirjavainen PV, Apostolou E, Arvola T, et al. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease[J]. FEMS Immunol Med Microbiol, 2001,32(1):1⁃7. doi: 10.1111/j.1574⁃695X.2001.tb00 526.x.
|
[9] |
Kalliomäki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing[J]. J Allergy Clin Immunol, 2001,107(1):129⁃134. doi: 10.1067/mai.2001.111237.
|
[10] |
Watanabe S, Narisawa Y, Arase S, et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects[J]. J Allergy Clin Immunol, 2003,111(3):587⁃591.
|
[11] |
Penders J, Thijs C, van den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study[J]. Gut, 2007,56(5):661⁃667. doi: 10.1136/gut.2006.100164.
|
[12] |
Song H, Yoo Y, Hwang J, et al. Faecalibacterium prausnitzii subspecies⁃level dysbiosis in the human gut microbiome underlying atopic dermatitis[J]. J Allergy Clin Immunol, 2016,137(3):852⁃860. doi: 10.1016/j.jaci.2015.08.021.
|
[13] |
Suzuki S, Campos⁃Alberto E, Morita Y, et al. Low Interleukin 10 production at birth is a risk factor for atopic dermatitis in neonates with bifidobacterium colonization[J]. Int Arch Allergy Immunol, 2018,177(4):342⁃349. doi: 10.1159/000492130.
|
[14] |
Nowrouzian FL, Lina G, Hodille E, et al. Superantigens and adhesins of infant gut commensal Staphylococcus aureus strains and association with subsequent development of atopic eczema[J]. Br J Dermatol, 2017,176(2):439⁃445. doi: 10.1111/bjd. 15138.
|
[15] |
Lee MJ, Kang MJ, Lee SY, et al. Perturbations of gut microbiome genes in infants with atopic dermatitis according to feeding type[J]. J Allergy Clin Immunol, 2018,141(4):1310⁃1319. doi: 10. 1016/j.jaci.2017.11.045.
|
[16] |
Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography[J]. Nature, 2012,486(7402):222⁃227. doi: 10.1038/nature11053.
|